SHEL.UK

3,444.5

+2.35%↑

BP

556.9

+3.47%↑

REN

28.26

-1.12%↓

SN.UK

1,202

+1.05%↑

SDR

573

+0.17%↑

SHEL.UK

3,444.5

+2.35%↑

BP

556.9

+3.47%↑

REN

28.26

-1.12%↓

SN.UK

1,202

+1.05%↑

SDR

573

+0.17%↑

SHEL.UK

3,444.5

+2.35%↑

BP

556.9

+3.47%↑

REN

28.26

-1.12%↓

SN.UK

1,202

+1.05%↑

SDR

573

+0.17%↑

SHEL.UK

3,444.5

+2.35%↑

BP

556.9

+3.47%↑

REN

28.26

-1.12%↓

SN.UK

1,202

+1.05%↑

SDR

573

+0.17%↑

SHEL.UK

3,444.5

+2.35%↑

BP

556.9

+3.47%↑

REN

28.26

-1.12%↓

SN.UK

1,202

+1.05%↑

SDR

573

+0.17%↑

Search

DCC PLC

Atidarymo kaina

SektoriusEnergijos sektorius

4,570 0.53

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

4518

Max

4600

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-116M

-4.1M

Pardavimai

-1.3B

7.4B

P/E

Sektoriaus vid.

35.569

66.822

Pelnas, tenkantis vienai akcijai

1.3

Dividendų pajamingumas

4.45

Pelno marža

-0.056

Darbuotojai

16,700

EBITDA

-113M

260M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+26.69% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

4.45%

3.56%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-901M

3.9B

Ankstesnė atidarymo kaina

4569.47

Ankstesnė uždarymo kaina

4570

Naujienos nuotaikos

By Acuity

40%

60%

43 / 137 reitingas Energy

DCC PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-23 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

2026-03-23 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

2026-03-23 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

2026-03-23 23:59; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-23 23:59; UTC

Rinkos pokalbiai

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

2026-03-23 23:50; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

2026-03-23 23:37; UTC

Rinkos pokalbiai

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

2026-03-23 22:40; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

2026-03-23 22:23; UTC

Rinkos pokalbiai

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

2026-03-23 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

2026-03-23 22:18; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

2026-03-23 22:15; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

2026-03-23 22:08; UTC

Rinkos pokalbiai

Ebos Needs to Reset Its Gearing Targets -- Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

2026-03-23 21:10; UTC

Svarbiausios naujienos

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

2026-03-23 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai
Uždarbis
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

DCC PLC Prognozė

Kainos tikslas

By TipRanks

26.69% į viršų

12 mėnesių prognozė

Vidutinis 5,731.6 GBX  26.69%

Aukščiausias 6,500 GBX

Žemiausias 4,708 GBX

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines DCC PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

5 ratings

3

Pirkti

2

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

43 / 137 reitingas Energijos sektorius

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę DCC PLC

DCC plc engages in the sales, marketing, and distribution of carbon energy solutions worldwide. The company operates through DCC Energy, DCC Healthcare, and DCC Technology segments. It sells transport and commercial fuels, heating oils and related products, liquid gas, refrigerants, electricity, and natural gas; sells and installs solar panels and energy efficiency solutions; operates a network of retail forecourts on motorways and in urban areas that provides fuel and EV charging; and offers multi-fuel bunkering and value add services for small/mid-sized fleets. It also offers medical devices for use in minimally invasive surgeries and related procedures in therapy areas, such as gastroenterology and urology; markets and sells medial consumables and equipment to including GPs, community healthcare providers, retail pharmacies, and emergency services; manufactures products for health and beauty brand owners; and develops and manufactures nutritional supplements and beauty products comprising tablets, capsules, gummies, soft gels, effervescents, powders, creams and liquids. In, addition it sells Pro Tech, which bring professional technologies together to enhance audio and visual experiences; Life Tech that provides technology to make high-quality lifestyles happen; and Info Tech to make faster connections happen. The company was incorporated in 1976 and is headquartered in Dublin, Ireland.
help-icon Live chat